09/19/2023
3:43 PM | ESSA Pharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
09/18/2023
6:05 AM | ESSA Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/15/2023
6:56 PM | ESSA Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2023
6:15 AM | ESSA Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2023
6:01 AM | ESSA Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/06/2023
3:30 PM | ESSA Pharma (Issuer)
Merendino Lauren (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/09/2023
8:01 AM | ESSA Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
05/09/2023
6:01 AM | ESSA Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/12/2023
6:02 AM | ESSA Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/10/2023
11:50 AM | ESSA Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2023
2:52 PM | Avidity Partners Management LP (Filed by)
ESSA Pharma (Subject)
| Form SC 13G/A | |
02/14/2023
1:50 PM | ESSA Pharma (Subject)
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
02/09/2023
9:37 AM | ESSA Pharma (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
02/07/2023
6:01 AM | ESSA Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
02/07/2023
6:02 AM | ESSA Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/24/2023
2:56 PM | ESSA Pharma (Filer)
| Form DEF 14A | |
01/05/2023
5:18 PM | ESSA Pharma (Issuer)
Parkinson David Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2023
2:41 PM | BERGER FRANKLIN M (Reporting)
ESSA Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2023
2:07 PM | ESSA Pharma (Issuer)
ESSA Pharma (Issuer)
Wood David S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2022
6:01 AM | ESSA Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
12/13/2022
6:01 AM | ESSA Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2022
10:04 AM | BERGER FRANKLIN M (Reporting)
ESSA Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2022
10:05 AM | Cesano Alessandra (Reporting)
ESSA Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2022
10:05 AM | ESSA Pharma (Issuer)
Glickman Richard M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2022
10:06 AM | ESSA Pharma (Issuer)
Martin John Alexander (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2022
10:06 AM | ESSA Pharma (Issuer)
Parkinson David Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2022
10:07 AM | ESSA Pharma (Issuer)
Requadt Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2022
10:08 AM | ESSA Pharma (Issuer)
Sollis Gary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2022
10:08 AM | ESSA Pharma (Issuer)
Thorell Marella (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2022
10:09 AM | ESSA Pharma (Issuer)
Virsik Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2022
10:09 AM | ESSA Pharma (Issuer)
Wood David S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2022
10:10 AM | ESSA Pharma (Issuer)
ZWEIFACH SANFORD S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2022
6:11 AM | ESSA Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/28/2022
1:57 PM | BB BIOTECH AG (Reporting)
BIOTECH GROWTH N V (Reporting)
ESSA Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/27/2022
8:56 AM | Avidity Partners Management LP (Filed by)
ESSA Pharma (Subject)
| Form SC 13G | |
10/26/2022
6:33 AM | ESSA Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
